Type 2 Diabetes Trial, Recruiting (NCT06906640)

Type 2 Diabetes Trial, Recruiting NCT06906640 Sponsor: Duke University Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06906640 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult diagnosed with type 2 diabetes
You have received primary care from a doctor or healthcare provider within the last 24 months
Your recent lab tests (within the last 2 years) show signs of chronic kidney disease — this includes having high levels of protein in your urine, reduced kidney function, or both (confirm with trial site if your tests are older than 3 months)
You are not currently taking the full recommended set of medications for managing kidney disease related to diabetes (confirm with trial site which medications apply to your situation)

Who may not be able to join:

You have type 1 diabetes (rather than type 2)
Your most recent kidney function test shows your kidneys are working at a very low level (confirm with trial site)
You have previously had a kidney transplant
You have a genetic kidney condition called autosomal dominant polycystic kidney disease (ADPKD) (confirm with trial site)
You are currently pregnant or planning to become pregnant within the next year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06906640

Sponsor: Duke University

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

More information: https://clinicaltrials.gov/study/NCT06906640

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult diagnosed with type 2 diabetes
You have received primary care from a doctor or healthcare provider within the last 24 months
Your recent lab tests (within the last 2 years) show signs of chronic kidney disease — this includes having high levels of protein in your urine, reduced kidney function, or both (confirm with trial site if your tests are older than 3 months)
You are not currently taking the full recommended set of medications for managing kidney disease related to diabetes (confirm with trial site which medications apply to your situation)

Who may not be able to join:

You have type 1 diabetes (rather than type 2)
Your most recent kidney function test shows your kidneys are working at a very low level (confirm with trial site)
You have previously had a kidney transplant
You have a genetic kidney condition called autosomal dominant polycystic kidney disease (ADPKD) (confirm with trial site)
You are currently pregnant or planning to become pregnant within the next year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Duke University

Registry

ClinicalTrials.gov

Start date

28 October 2025

Est. completion

1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CKD GDMT Opportunity Score at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov